Injection site reactions With subcutaneous administration, redness, itching, or irritation at the injection site may occur
While these medications offer profound weight loss results, they have created a new clinical challenge known as "Ozempic Body" or "Ozempic Face", characterized by significant skin laxity and muscle loss due to rapid weight reduction
Regul Pept 175:2129 Lu N, Sun H, Yu J, Wang X, Liu D, Zhao L, Sun L, Zhao H, Tao B, Liu J (2015) Glucagon-like peptide-1 receptor agonist liraglutide has anabolic bone effects in ovariectomized rats without diabetes
A 10mg melanotan 2 vial is sufficient for two courses at 0.25mg/daily or a single course at 0.5mg/daily
The satiety effect of liraglutide was documented to generate weight loss of 3.38 kg in clinical trials, making it ideal for obese patients with type 2 diabetes mellitus